Patients with COPD are often affected by sarcopenia, but the underlying mechanisms for the development are poorly understood. New research looks into the causes and potential therapies.
Using a multifaceted approach, Cleveland Clinic researchers have discovered molecular pathways that illuminate hyperammonemia’s role in the pathogenesis of sarcopenia, laying the groundwork for future therapies.
A clinical hepatologist’s quest for answers about muscle-wasting in cirrhosis led to a change in career path and major discoveries as a renowned sarcopenia researcher.
A new study of patients with early breast cancer suggests that the noninvasive assessment of sarcopenia using bioelectrical impedance analysis can help predict toxicity from adjuvant or neoadjuvant chemotherapy.